-
Dr Tolaney on the PFS Benefit With First-Line T-DXd Plus Pertuzumab in HER2+ Breast Cancer
03 Jun 2025 00:13 GMT
… with standard-of-care trastuzumab (Herceptin) plus pertuzumab and a taxane … HER2-positive advanced/metastatic breast cancer.
-
Trastuzumab Deruxtecan Plus Pertuzumab Improves PFS vs Standard Care in HER2+ Breast Cancer
02 Jun 2025 18:50 GMT
… breast cancer has been a taxane given with trastuzumab (Herceptin; … or metastatic HER2-positive breast cancer to receive either … with metastatic, HER2-positive breast cancer,” Tolaney said.
The … for HER2-positive metastatic breast cancer (CLEOPATRA): end-of …
-
Initial Enhertu Combo Improves Survival in HER2+ Advanced Breast Cancer
02 Jun 2025 18:41 GMT
… positive advanced or metastatic breast cancer, according to findings from … a taxane plus trastuzumab (Herceptin) and Perjeta. In the … with metastatic HER2-positive breast cancer.”
According to Tolaney, … or metastatic HER2-positive breast cancer, and no prior …
-
ASCO: AstraZeneca, Daiichi flex Enhertu's muscles in first-line breast cancer as they drop new phase 3 gastric cancer data
02 Jun 2025 17:14 GMT
… treatment for HER2-positive breast cancer, AstraZeneca and Daiichi Sankyo … option for HER2-positive breast cancer, Rebecca Dent, M. … HER2-positive early-stage breast cancer. The Destiny-Breast05 trial … antibody rilvegostomig either with Herceptin and chemo or …
-
Enhertu potential broadens as new data point to frontline breast cancer role
02 Jun 2025 13:14 GMT
… the treatment of metastatic breast cancer.
Already enmeshed in … Perjeta, the stalwart breast cancer drug Herceptin and chemotherapy.
The … focused on people whose breast tumors were either locally advanced … 15% to 20% of breast cancers are HER2-positive and …
-
First-Line T-DXd Plus Pertuzumab Yields PFS Benefit in HER2+ Advanced Breast Cancer
02 Jun 2025 12:07 GMT
… with a taxane plus trastuzumab (Herceptin) and pertuzumab (THP) in … patients with metastatic HER2-positive breast cancer.”
According to Tolaney, the … pertuzumab in HER2-positive metastatic breast cancer (DESTINY-Breast09). ClinicalTrials.gov. Updated …
-
Dr Desai on the PATINA Study of a Palbociclib-Based Regimen in HR+/HER2+ Metastatic Breast Cancer
31 May 2025 02:10 GMT
… –positive/HER2-positive metastatic breast cancer.
The randomized, international, open- … of palbociclib added to trastuzumab (Herceptin) with or without pertuzumab (Perjeta … positive/HER2-positive metastatic breast cancer, the current standard of care …
-
Pivotal Presentations That May Shape the Breast Cancer Standard of Care
30 May 2025 20:59 GMT
… of continued innovation in breast cancer therapy,” according to … a taxane, trastuzumab [Herceptin], and pertuzumab.1 But … for metastatic triple-negative breast cancer [TNBC]. We heard … with HER2-positive metastatic breast cancer. News release. AstraZeneca. …
-
Tolaney’s ‘What to Watch’: Key Breast Cancer Abstracts at ASCO 2025
30 May 2025 19:28 GMT
… , highlights a transformative year for breast cancer research at this year’s … at ASCO. I think, for breast cancer, it is a very exciting … neoadjuvant therapy using taxane, trastuzumab (Herceptin), and pertuzumab (Perjeta), alongside biomarker …
-
The truth about MALE breast cancer: As a man, I never knew I could get it... until I discovered these easily missed symptoms everyone must watch out for
29 May 2025 13:07 GMT
… with breast cancer have the BRCA2 breast cancer susceptibility … symptoms of breast cancer
Symptoms of breast cancer to look … breast cancer can also seek help from Breast Cancer … stop breast cancer growing – including tamoxifen and trastuzumab (Herceptin)
…
About
© 1995-2025